user

Optical coherence tomography in Huntington's disease: a potential biomarker for cognitive decline?

被引：0
|
作者：
Monteiro, A. [1 ]
Costa, A. [1 ]
Andrade, C. [1 ]
Beato, J. [2 ]
Penas, S. [2 ]
Guimaraes, J. [1 ]
Reis, F. [2 ]
Garrett, C. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Neurol, Oporto, Portugal
[2] Ctr Hosp Sao Joao, Ophthalmol, Oporto, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1234
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression
    Hannah M. Kersten
    Helen V. Danesh-Meyer
    Dean H. Kilfoyle
    Richard H. Roxburgh
    Journal of Neurology, 2015, 262 : 2457 - 2465
  • [2] Optical Coherence Tomography Findings in Huntington's Disease: a Potential Biomarker of Disease Progression?
    Kersten, Hannah Maree
    Danesh-Meyer, Helen V.
    Kilfoyle, Dean H.
    Roxburgh, Richard H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [3] OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN HUNTINGTON'S DISEASE: A POTENTIAL BIOMARKER OF DISEASE PROGRESSION
    Kersten, Hannah
    Danesh-Meyer, Helen
    Kilfoyle, Dean
    Roxburgh, Richard
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A36 - A36
  • [4] Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression
    Kersten, Hannah M.
    Danesh-Meyer, Helen V.
    Kilfoyle, Dean H.
    Roxburgh, Richard H.
    JOURNAL OF NEUROLOGY, 2015, 262 (11) : 2457 - 2465
  • [5] Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease
    Uzun, Salih
    Pehlivan, Emre
    MOVEMENT DISORDERS, 2016, 31 (11) : 1762 - 1762
  • [6] Optical Coherence Tomography in Huntington's Disease-A Potential Future Biomarker for Neurodegeneration?
    Cerejo, Clancy
    De Cleene, Nicolas
    Mandler, Elias
    Schwarzova, Katarina
    Labrecque, Samuel
    Mahlknecht, Philipp
    Krismer, Florian
    Djamshidian, Atbin
    Seppi, Klaus
    Heim, Beatrice
    NEUROLOGY INTERNATIONAL, 2025, 17 (01):
  • [7] Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease
    Andrade, Carlos
    Beato, Joao
    Monteiro, Ana
    Costa, Andreia
    Penas, Susana
    Guimaraes, Joana
    Reis, Fernando Falcao
    Garrett, Carolina
    MOVEMENT DISORDERS, 2016, 31 (03) : 377 - 383
  • [8] Spectral-domain Optical Coherence Tomography in Huntington Disease: Potential Biomarker?
    Bicho Beato, Joao Nuno
    Andrade, Carlos
    Monteiro, Ana
    Costa, Andreia
    Guimaraes, Joana
    Garrett, Carolina
    Brandao, Elisete
    Falcao-Reis, Fernando
    Penas, Susana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [9] Is retina affected in Huntington's disease? Is optical coherence tomography a good biomarker?
    Dusek, Pavel
    Kopal, Ales
    Brichova, Michaela
    Roth, Jan
    Ulmanova, Olga
    Klempir, Jiri
    Preiningerova, Jana Lizrova
    Neueder, Andreas
    Lewin, Alfred S.
    PLOS ONE, 2023, 18 (02):
  • [10] Optical coherence tomography in Huntington's disease
    Parisi, V.
    Gatto, E.
    Ochoa, S.
    Scocco, D.
    Fernandez Rey, E.
    MOVEMENT DISORDERS, 2015, 30 : S141 - S142
12345